Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

Item
http://www.wikidata.org/entity/Q43855238
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab.[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China.Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis.Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.Efficacy and safety of rituximab in rheumatic diseases.Scleroderma renal crisis and renal involvement in systemic sclerosis.[Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)].Moderator's view: Should all patients with ANCA-associated vasculitis be primarily treated with rituximab?Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].
P2860

Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

Item
http://www.wikidata.org/entity/Q43855238
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Efficacy and safety of rituxim ...... rom a German registry (GRAID).
@en
Efficacy and safety of rituxim ...... results from a German registry
@nl
type
label
Efficacy and safety of rituxim ...... rom a German registry (GRAID).
@en
Efficacy and safety of rituxim ...... results from a German registry
@nl
prefLabel
Efficacy and safety of rituxim ...... rom a German registry (GRAID).
@en
Efficacy and safety of rituxim ...... results from a German registry
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Efficacy and safety of rituxim ...... rom a German registry (GRAID).
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698